June 28, 2025 - 01:52

MIT and Mass General Brigham (MGB) have announced the launch of the MIT-MGB Seed Program, a new initiative aimed at accelerating advancements in healthcare. This program, made possible through a generous contribution from Analog Devices, seeks to foster innovative research that can lead to the development of next-generation therapies, diagnostics, and digital health tools.
The primary objective of the Seed Program is to enhance human health by supporting groundbreaking projects that have the potential to make a significant impact on patient care and treatment outcomes. By combining the expertise of MIT’s cutting-edge research capabilities with MGB’s clinical experience, the collaboration aims to bridge the gap between scientific discovery and practical application in the healthcare sector.
Through this initiative, researchers will be encouraged to explore novel ideas and technologies that address pressing health challenges, ultimately leading to solutions that can improve lives on a large scale. The program represents a significant step forward in the ongoing effort to innovate within the healthcare landscape.
October 8, 2026 - 18:55
New Jersey Grows Doula Training Network to 29 Approved ProgramsNew Jersey has expanded the number of doula training programs approved under NJ FamilyCare, bringing the total to 29 across the state. The move aims to widen access to doula support for residents...
October 8, 2026 - 04:20
Blue Cross Downcoding Practices Hit Behavioral Health Providers Across Several StatesBehavioral health providers in at least three states are dealing with downcoding actions from Blue Cross Blue Shield plans, according to reporting from BHB+. The issue involves claims being paid at...
October 7, 2026 - 04:49
Brooklyn Hospital Debuts Massive Mural Focused on Healing and ResilienceA new large-scale mural has transformed a busy corridor at a Brooklyn medical facility, turning a clinical passageway into a space that speaks to recovery, strength, and optimism. The artwork,...
October 6, 2026 - 12:29
The Case Against Approving a Flawed Multicancer Screening TestTelling more people they have cancer is not progress; progress is having fewer people die from cancer. That argument sits at the center of a growing debate over whether regulators should clear a...